Ylva Almqvist

Biodistribution of 211At labeled HER-2 binding affibody molecules in mice

Ann-Charlott Steffen, Ylva Almqvist, Ming‐Kuan Chyan et al. · Oncology Reports · 2007 · 35 citations · Full text

Combined effect of gefitinib ('Iressa', ZD1839) and targeted radiotherapy with 211 At-EGF

�sa Liljegren Sundberg, Ylva Almqvist, Anna Orlova et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2003 · 30 citations

Radiation Medicine, Radiation Therapy, Medicine +7

In vitro and in vivo characterization of 177Lu-huA33

Ylva Almqvist, Ann-Charlott Steffen, Vladimir Tolmachev et al. · Nuclear Medicine and Biology · 2006 · 20 citations

Pharmacology, Biomedical Research, Vivo Characterization

[99mTc] HYNIC-hEGF, a potential agent for imaging of EGF receptors in vivo: Preparation and pre-clinical evaluation

Mohammad Babaei, Ylva Almqvist, Anna Orlova et al. · Oncology Reports · 2005 · 16 citations

Treatment of cultured glioma cells with the EGFR-TKI gefitinib ("Iressa", ZD1839) increases the uptake of astatinated EGF despite the absence of gefitinib-mediated growth inhibition

Åsa Liljegren Sundberg, Ylva Almqvist, Vladimir Tolmachev et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2003 · 16 citations

Neuro-oncology, Glioma, Medicine +11